Patents Examined by J. D. Wesserdorf
  • Patent number: 5493006
    Abstract: Improved CRF peptide antagonists have the formula: ##STR1## wherein R.sub.20 is Cys or Glu; R.sub.23 is Cys, Lys or Orn; provided that when R.sub.20 is Cys, R.sub.23 is Cys and when R.sub.20 is Glu, R.sub.23 is Lys or Orn; or a nontoxic addition salt thereof. Specific CRF antagonists disclosed include (cyclo 20-23) [D-Phe.sup.12, Lys.sup.23, Nle.sup.21,38, ]rCRF(12-41); (cyclo 20-23) [D-Phe.sup.12, Orn.sup.23, Nle.sup.21,38 ]rCRF(12-41) and (cyclo 20-23) [D-Phe.sup.12, Cys.sup.20, Cys.sup.23, Nle.sup.21,38 ]rCRF(12-41).
    Type: Grant
    Filed: June 16, 1993
    Date of Patent: February 20, 1996
    Assignee: The Salk Institute for Biological Studies
    Inventors: Antonio de Miranda, Wylie W. Vale, Jr., Jean E. F. Rivier, Catherine L. Rivier